Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.


Insomnia is characterised by problems with starting and/or maintaining sleep. This can have an affect on the quality of life for those with insomnia. 10-12% of adults in Europe are affected by Insomnia. There are also associated costs with Insomnia, including increased healthcare use, reduced productivity and accidents.

Study Design: Parallel, open-label, randomised-contolled trial

University of Oxford

Ethical Approval:
Contact Details:

Chief Investigator:

Doctor Simon Kyle

Trial management: